Work

Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity

Year: 2009

Type: article

Source: Cancer Gene Therapy

DOI: 10.1038/cgt.2009.17

Authors: T Osada, X Y Yang, Z C Hartman, O Glass, B L Hodges, D Niedzwiecki, M A Morse, H K Lyerly, A Amalfitano, T M Clay

Institutions: Duke Medical Center, Prothelia (United States), Duke University, Michigan State University

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: Immunotherapy with High Frequency, CEA Specific T Cells, G8774204302

OpenAlex ID: W2029445351

FWCI: 4.069

Cites: 33

Cited by: 52

Related to: 10